Navigation Links
British Woman Celebrates a Year of Living Cancer-Free
Date:7/30/2009

LONDON, July 30 /PRNewswire/ -- It's been a year since fashion designer Joanne Scott went through a cancer treatment that changed her life -- and made history to boot.

Ms. Scott, 54, was the first person in the world to receive an injection of tumor-activated natural killer (TaNK) cells as a treatment for leukemia.

Her doctors at the Royal Free Hospital in London recommended this experimental therapy after two years of traditional treatments, including chemotherapy and a bone marrow transplant, failed to keep her in remission. Ms. Scott didn't expect it to work. "I thought that I was gonna get really sick again," she said, "like I had before."

But the new treatment succeeded where the others had failed, sparking hope among oncologists that TaNK cells could be the key to a new type of advanced cancer therapy.

Doctors at the Royal Free injected Ms. Scott with natural killer (NK) cells taken from her daughter, Tara, who was 21 at the time. The next day, Ms. Scott was able to go home from the hospital.

"I felt fine immediately. I was going out to dinner and things like that," Ms. Scott said. "It was really nice after all the other treatments I've had, which were very, very grueling."

The idea behind the new treatment is this: NK cells, which are part of the body's immune system, will target and fight any leukemia cells that survive chemotherapy if they are activated to fight the cancer. In cancer patients, however, the NK cells are not activated and do not attack the cancer cells.

Ms. Scott's doctors activated the cells they took from her daughter into TaNK cells, which can kill even NK-resistant tumors. Within a week of the injection, the TaNK cells had survived and multiplied. Within a month, a study of her bone marrow -- the site affected by the type of leukemia she had -- confirmed that the TaNK
'/>"/>

SOURCE Coronado BioSciences
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. The University of Nottingham in the British Midlands Announces Breakthrough in Parkinsons Disease Research
2. British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection
3. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
4. Congresswoman Supporting Spinal Cord Research Intended to Benefit U.S. Veterans
5. Melanoma and Pregnancy: What Every Woman Needs to Know About the Risks, Prognosis
6. Recipient of Melanoma Drug in Development Celebrates Two Cancer-Free Years
7. Getty Images Celebrates Conclusion of Change Me Imagery Forum
8. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
9. BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment
10. American Lung Association Celebrates 101st Annual Christmas Seals Campaign
11. Study Confirms That Avastin Significantly Increases Chance of Living Without Disease Progression in Metastatic Breast Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...rstCall/--Immucor,Inc.(Nasdaq: BLUD ),agloballeade...ebloodtransfusionindustry,todayannouncedthataccess...CareConferenceinNewYork,NYwillbeavailableviaalive,...nisscheduledforTuesday,December1,2009,at12:30p.m.E...hroughthe"AboutUs--InvestorInformation"sectionatww...
(Date:11/23/2009)...swire-FirstCall/--TransceptPharmaceuticals,Inc.(Na...iththeU.S.FoodandDrugAdministration(FDA)onJanuary2...heNewDrugApplication(NDA)for Intermezzo ® (z...nced,theCompleteResponseLetter,receivedbyTranscept...etheNDAinitspresentform.TheNDAseeksapprovaltomarke...
(Date:11/23/2009)...wire-FirstCall/--BeckmanCoulter,Inc.(NYSE: BEC ),a...sthatsimplify,automate,andinnovatecomplexbiomedica...ter,svicepresidentofstrategy,willpresentatthePiper...009at12:00p.m.(ET). ,, (Logo: http://www.newsco...ewebcastofBeckmanCoulter,spresentationcanbeaccesse...
Breaking Medicine Technology:Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter 2Ceremony at Passavant Area Hospital to Launch Efficiency Improvements 48899 1Ceremony at Passavant Area Hospital to Launch Efficiency Improvements 48899 2Ceremony at Passavant Area Hospital to Launch Efficiency Improvements 48899 3Hebrew University research leads to advanced trials of new cancer treatment 48895 1Hebrew University research leads to advanced trials of new cancer treatment 48895 2Broecker 3A What we need are tougher measures against climate change 8830 1Broecker 3A What we need are tougher measures against climate change 8830 2Broecker 3A What we need are tougher measures against climate change 8830 3
...N, Mass., May 21 Pressure,BioSciences, Inc. (Nasd...s,from the New York University (NYU) School of Med...rd School of Public Health made presentations,high...pressure cycling,technology (PCT) at three differe...re three oral presentations and four poster presen...
...ented at American Urological Association Annual Me...rchers,from Dendreon Corporation (Nasdaq: DNDN ) ... potential of D-3263, Dendreon,s orally bioavailab...mbrane cation channel protein also,known as Trp-M8...The abstract (#2041), "Preclinical Validation of t...
Other Medicine Technology:Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 2Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 3Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 4Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia 2Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia 3Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia 4
(Date:11/24/2009)...NGTON,Nov.24/PRNewswire-USNewswire/--Newpeer-revie...llionAmericansinfectedwithchronichepatitisCvirusha...ake-upcallthatCongressneedstomoveurgentlyonbiparti...earch,andsurveillanceefforts,the NationalViralHepa...sthatwithoutcongressionalaction,millionsofAmerican...
(Date:11/23/2009)...tobolomics study by researchers from Virginia Comm...nd that impaired peroxisomal oxidation of polyunsa...progression of nonalcoholic fatty liver (NAFL) to ...lso found significantly higher plasma monounsatura... and NASH. Full findings appear in the December i...
(Date:11/23/2009)...s may be on the hook for the high cost of drug adv...g to a new study led by a University of British Co...ublished today in the Archives of Internal Medici..., a top-selling drug also known by the trade name ...ack or stroke. The drug was selected to study the ...
(Date:11/23/2009)...icanCollegeofMedicalGenetics(ACMG)EncouragesFamili...FamilyHistoryDay,Thanksgiving2009 ,, BETHESDA,...gisthesixthannualNationalFamilyHistoryDay,asdeclar...calGenetics(ACMG)encourageseveryonetoknowtheirfami...spotentiallylife-savinginformation,to"starttheconv...
(Date:11/23/2009)...RO,Pa.,Nov.23/PRNewswire-FirstCall/--InfoLogix,Inc...prisemobilitysolutionsforthehealthcareandcommercia...sidentofManagedServicesatSiemensHealthServices,has...eServices. ,, (Logo: http://www.newscom.com/cgi...dentofStrategicHealthcareServicesforInfoLogix,Mr.W...
Breaking Medicine News(10 mins):Health News:NVHR: New Data Finding Fewer than 1 in 5 Hepatitis C Patients Receiving Antiviral Therapy is 'Wake-Up Call' for Washington 2Health News:Metobolomics uncovers key indicators of nonalcoholic fatty liver disease 2Health News:Drug ads ineffective for boosting sales, could cost taxpayers: UBC-Harvard study 2Health News:'Family Health History and Genetics Privacy' is the Newest Addition to the ACMG Genetics & Your Health Video Series 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3
...sly Recommended That NMHC,s Stockholders Accept ... and PORT WASHINGTON, NY, March 31 /PRNewswire-Fir...aq: SXCI ; TSX: SXC) and National,Medical Health ...today an exchange offer for all of the outstanding...
...bout risks and benefits of mastectomies or lumpect...s) -- Only half the women diagnosed with early-sta...benefits of a mastectomy versus a breast-conservin...e even less likely she has adequate information, s...
... 31 CNS Response,Inc. (OTC Bulletin Board: CNSO) ...t to roll out referenced-EEG(R) (rEEG(R)) availabi...ral health organization (MBHO). This,agreement ena... suffering any of the behavioral disorders with,th...
...-Vision Inc. (Nasdaq:,LCAV), a leading provider of...lus(R) brand, announced the opening of its 76th La.... This opening marks the fourth,LasikPlus(R) visio...pril 2006., Similar to other LasikPlus(R) vision ...
...ble laparoscopic instruments will give surgeons p... procedures while, delivering patient protection f... the healthcare industry, BOULDER,...simultaneously delivering increased,safety to pati...
...ch 31 Ingenuity Systems, the,leading provider of ...,announced today that Path Designer, the new pathw...est New Product by the scientific community in,att...s to more clearly communicate their experimental f...
Other Medicine News:Health News:SXC Health Solutions Corp. Commences Exchange Offer For Shares Of National Medical Health Card Systems, Inc. 2Health News:SXC Health Solutions Corp. Commences Exchange Offer For Shares Of National Medical Health Card Systems, Inc. 3Health News:SXC Health Solutions Corp. Commences Exchange Offer For Shares Of National Medical Health Card Systems, Inc. 4Health News:SXC Health Solutions Corp. Commences Exchange Offer For Shares Of National Medical Health Card Systems, Inc. 5Health News:Many Women Unclear About Breast Cancer Treatments 2Health News:CNS Response, Inc. Enters Agreement to Introduce rEEG(R) Platform to Managed Behavioral Health Organization 2Health News:CNS Response, Inc. Enters Agreement to Introduce rEEG(R) Platform to Managed Behavioral Health Organization 3Health News:CNS Response, Inc. Enters Agreement to Introduce rEEG(R) Platform to Managed Behavioral Health Organization 4Health News:LCA-Vision Announces the Opening of its 76th LasikPlus(R) Vision Center in Woodbridge, New Jersey 2Health News:Encision Moves Power and Safety to Surgeons' Fingertips 2Health News:Ingenuity's Path Designer is Selected as Best New Product by Life Science Community at 2008 Molecular Medicine Conference 2Health News:Ingenuity's Path Designer is Selected as Best New Product by Life Science Community at 2008 Molecular Medicine Conference 3
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
Medicine Products: